Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer

PURPOSE: To determine whether serum follicle-stimulating hormone (FSH) can be used to predict the aggressiveness of prostate cancer prior to radical prostatectomy. METHODS: Ninety-six patients who underwent radical prostatectomy for biopsy proved cT1c-T2N0M0 prostate cancer between 2003 and 2008 wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ide, Hisamitsu, Terado, Yuichi, Sakamaki, Kentaro, Inoue, Masahiro, Nakajima, Akiko, Lu, Yan, Hisasue, Schinichi, Yamaguchi, Raizo, Muto, Satoru, Horie, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society (APPS) 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814124/
https://www.ncbi.nlm.nih.gov/pubmed/24223411
http://dx.doi.org/10.12954/PI.13019